<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Radiopharm Theranostics Expands Market Presence with New ASX Quotation

PremiumCompany Announcements

2d ago

Radiopharm granted U.S. FDA FTD for RAD101

PremiumThe Fly

2d ago

Radiopharm Theranostics’ RAD 101 Receives FDA Fast Track Designation

PremiumCompany Announcements

3d ago

Radiopharm Theranostics Announces New Securities Issue

PremiumCompany Announcements

4d ago

PremiumThe FlyRadiopharm announces dosing of first patient in Phase 1 HEAT trial

9d ago

Radiopharm Theranostics Initiates Phase 1 Trial for Novel Cancer Treatment

Company Announcements

Radiopharm Theranostics Initiates Phase 1 Trial for Novel Cancer Treatment

10d ago

Radiopharm reports preclinical Lu177-B7H3-mAb data

The Fly

Radiopharm reports preclinical Lu177-B7H3-mAb data

11d ago

Radiopharm Theranostics Advances RV01 Program with Promising Preclinical Data

PremiumCompany Announcements

12d ago

Radiopharm Theranostics Director Increases Shareholding

PremiumCompany Announcements

14d ago

Radiopharm pipeline ‘dramatically’ undervalued, says JonesResearch

PremiumThe Fly

22d ago

Radiopharm, ITM sign supply agreement for n.c.a. Lutetium-177

PremiumThe Fly

25d ago

PremiumThe FlyRadiopharm says DSMC says Phase 1 study may continue as planned

1M ago

Radiopharm initiated with a Buy at ThinkEquity

The Fly

Radiopharm initiated with a Buy at ThinkEquity

1M ago

Radiopharm Theranostics Advances Phase 1 Trial for 177Lu-RAD204

Company Announcements

Radiopharm Theranostics Advances Phase 1 Trial for 177Lu-RAD204

1M ago

Radiopharm Theranostic initiated with a Buy at Maxim

PremiumThe Fly

1M ago

Radiopharm Theranostics Advances in Clinical Trials and Secures Major Investment

PremiumCompany Announcements

2M ago

Radiopharm Theranostic doses first patient with 18F-RAD101 in Phase 2b study

PremiumThe Fly

2M ago

Radiopharm Theranostics Initiates U.S. Phase 2b Imaging Study for Brain Metastasis

PremiumCompany Announcements

2M ago

PremiumThe FlyRadiopharm Theranostic announces presentation of RAD202 data

3M ago

Radiopharm Theranostics Reports Positive Data on RAD202 for HER2-Positive Tumors

Company Announcements

Radiopharm Theranostics Reports Positive Data on RAD202 for HER2-Positive Tumors

3M ago

Radiopharm Theranostic initiated with a Buy at B. Riley

The Fly

Radiopharm Theranostic initiated with a Buy at B. Riley

3M ago